McGregor Narelle E, Poulton Ingrid J, Walker Emma C, Sims Natalie A
Bone Cell Biology and Disease Unit, St. Vincent's Institute of Medical Research, Melbourne, Australia.
Melbourne Medical School, The University of Melbourne, Melbourne, Australia.
Bio Protoc. 2020 Mar 20;10(6):e3560. doi: 10.21769/BioProtoc.3560.
Bone formation occurs during embryogenesis, skeletal growth and during the process of skeletal renewal throughout life. In the process of bone formation, osteoblasts lay down a collagen-containing matrix, termed osteoid, which is gradually hardened by incorporation of mineral crystals. Although osteoblasts can be induced to differentiate and to deposit mineral in culture, this system does not always provide results that reflect the ability of agents to stimulate bone formation . This protocol describes a rapid and reliable method for testing local administration of agents on bone formation In this method, mice are injected with the agent of question for 5 successive days. Fluorochrome labels are injected prior to, and after agents used for testing, and samples are collected and analysed by undecalcified bone histology and histomorphometry. This provides a robust method for assessing the ability of agents to stimulate bone formation, and if a short-term modification is used, can also be used for testing gene responses in bone to the same stimuli.
骨形成发生在胚胎发育、骨骼生长以及一生中骨骼更新的过程中。在骨形成过程中,成骨细胞分泌一种含胶原蛋白的基质,称为类骨质,它通过矿物质晶体的掺入逐渐硬化。尽管在培养中可以诱导成骨细胞分化并沉积矿物质,但该系统并不总是能提供反映药物刺激骨形成能力的结果。本方案描述了一种快速可靠的方法,用于测试局部给药药物对骨形成的影响。在该方法中,连续5天给小鼠注射受试药物。在使用受试药物之前和之后注射荧光染料标记,收集样本并通过不脱钙骨组织学和组织形态计量学进行分析。这提供了一种评估药物刺激骨形成能力的可靠方法,如果采用短期改良,还可用于测试骨骼对相同刺激的基因反应。